Lv7
4970 积分 2020-12-21 加入
PD-L1 inhibitor plus gemcitabine and cisplatin therapy followed by conversion surgery for initially unresectable advanced gallbladder cancer
12天前
已完结
Conversion surgery for initially unresectable biliary malignancies: a multicenter retrospective cohort study
12天前
已完结
肝细胞癌伴微血管侵犯诊断和治疗中国专家共识（2024版）
13天前
已完结
Lenvatinib combined with PD-1 inhibitor plus Gemox chemotherapy versus plus HAIC for advanced biliary tract cancer
15天前
已完结
[Expert consensus on PD-L1 expression testing in esophageal carcinoma in China]
1个月前
已完结
Cancer statistics, 2023
1个月前
已完结
Increased glucose availability sensitizes pancreatic cancer to chemotherapy
1个月前
已关闭
Cancer statistics in Chinese older people, 2022: current burden, time trends, and comparisons with the US, Japan, and the Republic of Korea
1个月前
已完结
Overview and countermeasures of cancer burden in China
1个月前
已完结
Pancreatic cancer: Advances and challenges
1个月前
已完结
皖公网安备34019202002308
